| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |